1. RTI Surgical signed an agreement to acquire Cook Biotech.
2. Kuros Biosciences hit three advancements for its MagnetOS portfolio.
3. Ossium Health’s OssiGraft viable bone matrix allograft was used in its first patient case.
4. Legislation has been introduced in the U.S. House that would require all bone graft material to be tested for active and latent tuberculosis. It would also expedite the process for developing a screening test.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
